Pharmacokinetics of enrofloxacin following intravenous administration to greater rheas: a preliminary study

The pharmacokinetic behaviour of enrofloxacin (ENR) and its active metabolite ciprofloxacin (CIP) were determined in six greater rheas following a single intravenous (i.v.) dose of 15 mg/kg bw. Plasma concentrations of ENR and CIP were simultaneously determined by a HPLC/u.v. method. Following i.v....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Research in veterinary science 2005-06, Vol.78 (3), p.265-267
Hauptverfasser: de Lucas, J.J., Rodríguez, C., Martella, M.B., Lábaque, M.C., Navarro, J.L., Andrés, M.I. San
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 267
container_issue 3
container_start_page 265
container_title Research in veterinary science
container_volume 78
creator de Lucas, J.J.
Rodríguez, C.
Martella, M.B.
Lábaque, M.C.
Navarro, J.L.
Andrés, M.I. San
description The pharmacokinetic behaviour of enrofloxacin (ENR) and its active metabolite ciprofloxacin (CIP) were determined in six greater rheas following a single intravenous (i.v.) dose of 15 mg/kg bw. Plasma concentrations of ENR and CIP were simultaneously determined by a HPLC/u.v. method. Following i.v. administration, the plasma drug concentrations were best fitted by an open two-compartment model with a rapid distribution phase. The high volume of distribution ( V ss = 5.01 L/Kg) suggests good tissue penetration. ENR presents a high clearance (3.95 L/kg h) explaining the low AUC values (3.57 mg h/L) and a short permanence (t 1/2β = 2.66 h and MRT = 1.23 h). Ciprofloxacin comprised 14% of the total fluoroquinolone (ENR + CIP).
doi_str_mv 10.1016/j.rvsc.2004.09.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67514196</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0034528804001870</els_id><sourcerecordid>2744856881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c406t-7ef14db6849dc15956d8500f9b953d843d19ffad291f7221261d0ab0eed835c13</originalsourceid><addsrcrecordid>eNp90U2LFDEQBuAgijuu_gEPGhC8dVtJd9Id8SKLX7CgoHsOmaQym9meZEy6R_ffm2EGBA-eAsVTRaVeQp4zaBkw-Wbb5kOxLQfoW1AtwPCArJjoeMOlZA_JCqDrG8HH8YI8KWULFTI2PCYXTAxSqn5YkbtvtybvjE13IeIcbKHJU4w5-Sn9NjZE6tM0pV8hbmiIczYHjGkp1LhdiKHUwhxSpHOim4xmxkzzLZrylhq6zziFqky-p2Ve3P1T8sibqeCz83tJbj5--HH1ubn--unL1fvrxvYg52ZAz3q3lmOvnGVCCelGAeDVWonOjX3nmPLeOK6YHzhnXDIHZg2IbuyEZd0leX2au8_p54Jl1rtQLE6TiVh313IQrGdKVvjqH7hNS451N82gE9DxsTsqflI2p1Iyer3PYVd_VZE-BqG3-hiEPgahQekaRG16cR69rHfo_racL1_ByxPwJmmzyaHom-8cWAegFPSir-LdSWC91SFg1sUGjBZdyGhn7VL43wZ_AMfypNU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1035032836</pqid></control><display><type>article</type><title>Pharmacokinetics of enrofloxacin following intravenous administration to greater rheas: a preliminary study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>de Lucas, J.J. ; Rodríguez, C. ; Martella, M.B. ; Lábaque, M.C. ; Navarro, J.L. ; Andrés, M.I. San</creator><creatorcontrib>de Lucas, J.J. ; Rodríguez, C. ; Martella, M.B. ; Lábaque, M.C. ; Navarro, J.L. ; Andrés, M.I. San</creatorcontrib><description>The pharmacokinetic behaviour of enrofloxacin (ENR) and its active metabolite ciprofloxacin (CIP) were determined in six greater rheas following a single intravenous (i.v.) dose of 15 mg/kg bw. Plasma concentrations of ENR and CIP were simultaneously determined by a HPLC/u.v. method. Following i.v. administration, the plasma drug concentrations were best fitted by an open two-compartment model with a rapid distribution phase. The high volume of distribution ( V ss = 5.01 L/Kg) suggests good tissue penetration. ENR presents a high clearance (3.95 L/kg h) explaining the low AUC values (3.57 mg h/L) and a short permanence (t 1/2β = 2.66 h and MRT = 1.23 h). Ciprofloxacin comprised 14% of the total fluoroquinolone (ENR + CIP).</description><identifier>ISSN: 0034-5288</identifier><identifier>EISSN: 1532-2661</identifier><identifier>DOI: 10.1016/j.rvsc.2004.09.007</identifier><identifier>PMID: 15766947</identifier><language>eng</language><publisher>England: Elsevier India Pvt Ltd</publisher><subject>Animals ; Anti-Bacterial Agents - administration &amp; dosage ; Anti-Bacterial Agents - blood ; Anti-Bacterial Agents - pharmacokinetics ; Area Under Curve ; Avian ; Behavior ; blood plasma ; Ciprofloxacin ; Ciprofloxacin - blood ; Ciprofloxacin - pharmacokinetics ; dosage ; Drug therapy ; Enrofloxacin ; Fluoroquinolones ; Fluoroquinolones - administration &amp; dosage ; Fluoroquinolones - blood ; Fluoroquinolones - pharmacokinetics ; Half-Life ; high performance liquid chromatography ; Injections, Intravenous - veterinary ; intravenous injection ; Mortality ; Pharmacokinetic ; pharmacokinetics ; Quinolones - administration &amp; dosage ; Quinolones - blood ; Quinolones - pharmacokinetics ; Rhea ; rheas ; Rheiformes - metabolism ; Software packages ; ultraviolet-visible spectroscopy ; Veterinary medicine ; young animals</subject><ispartof>Research in veterinary science, 2005-06, Vol.78 (3), p.265-267</ispartof><rights>2004 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c406t-7ef14db6849dc15956d8500f9b953d843d19ffad291f7221261d0ab0eed835c13</citedby><cites>FETCH-LOGICAL-c406t-7ef14db6849dc15956d8500f9b953d843d19ffad291f7221261d0ab0eed835c13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.rvsc.2004.09.007$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15766947$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Lucas, J.J.</creatorcontrib><creatorcontrib>Rodríguez, C.</creatorcontrib><creatorcontrib>Martella, M.B.</creatorcontrib><creatorcontrib>Lábaque, M.C.</creatorcontrib><creatorcontrib>Navarro, J.L.</creatorcontrib><creatorcontrib>Andrés, M.I. San</creatorcontrib><title>Pharmacokinetics of enrofloxacin following intravenous administration to greater rheas: a preliminary study</title><title>Research in veterinary science</title><addtitle>Res Vet Sci</addtitle><description>The pharmacokinetic behaviour of enrofloxacin (ENR) and its active metabolite ciprofloxacin (CIP) were determined in six greater rheas following a single intravenous (i.v.) dose of 15 mg/kg bw. Plasma concentrations of ENR and CIP were simultaneously determined by a HPLC/u.v. method. Following i.v. administration, the plasma drug concentrations were best fitted by an open two-compartment model with a rapid distribution phase. The high volume of distribution ( V ss = 5.01 L/Kg) suggests good tissue penetration. ENR presents a high clearance (3.95 L/kg h) explaining the low AUC values (3.57 mg h/L) and a short permanence (t 1/2β = 2.66 h and MRT = 1.23 h). Ciprofloxacin comprised 14% of the total fluoroquinolone (ENR + CIP).</description><subject>Animals</subject><subject>Anti-Bacterial Agents - administration &amp; dosage</subject><subject>Anti-Bacterial Agents - blood</subject><subject>Anti-Bacterial Agents - pharmacokinetics</subject><subject>Area Under Curve</subject><subject>Avian</subject><subject>Behavior</subject><subject>blood plasma</subject><subject>Ciprofloxacin</subject><subject>Ciprofloxacin - blood</subject><subject>Ciprofloxacin - pharmacokinetics</subject><subject>dosage</subject><subject>Drug therapy</subject><subject>Enrofloxacin</subject><subject>Fluoroquinolones</subject><subject>Fluoroquinolones - administration &amp; dosage</subject><subject>Fluoroquinolones - blood</subject><subject>Fluoroquinolones - pharmacokinetics</subject><subject>Half-Life</subject><subject>high performance liquid chromatography</subject><subject>Injections, Intravenous - veterinary</subject><subject>intravenous injection</subject><subject>Mortality</subject><subject>Pharmacokinetic</subject><subject>pharmacokinetics</subject><subject>Quinolones - administration &amp; dosage</subject><subject>Quinolones - blood</subject><subject>Quinolones - pharmacokinetics</subject><subject>Rhea</subject><subject>rheas</subject><subject>Rheiformes - metabolism</subject><subject>Software packages</subject><subject>ultraviolet-visible spectroscopy</subject><subject>Veterinary medicine</subject><subject>young animals</subject><issn>0034-5288</issn><issn>1532-2661</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90U2LFDEQBuAgijuu_gEPGhC8dVtJd9Id8SKLX7CgoHsOmaQym9meZEy6R_ffm2EGBA-eAsVTRaVeQp4zaBkw-Wbb5kOxLQfoW1AtwPCArJjoeMOlZA_JCqDrG8HH8YI8KWULFTI2PCYXTAxSqn5YkbtvtybvjE13IeIcbKHJU4w5-Sn9NjZE6tM0pV8hbmiIczYHjGkp1LhdiKHUwhxSpHOim4xmxkzzLZrylhq6zziFqky-p2Ve3P1T8sibqeCz83tJbj5--HH1ubn--unL1fvrxvYg52ZAz3q3lmOvnGVCCelGAeDVWonOjX3nmPLeOK6YHzhnXDIHZg2IbuyEZd0leX2au8_p54Jl1rtQLE6TiVh313IQrGdKVvjqH7hNS451N82gE9DxsTsqflI2p1Iyer3PYVd_VZE-BqG3-hiEPgahQekaRG16cR69rHfo_racL1_ByxPwJmmzyaHom-8cWAegFPSir-LdSWC91SFg1sUGjBZdyGhn7VL43wZ_AMfypNU</recordid><startdate>20050601</startdate><enddate>20050601</enddate><creator>de Lucas, J.J.</creator><creator>Rodríguez, C.</creator><creator>Martella, M.B.</creator><creator>Lábaque, M.C.</creator><creator>Navarro, J.L.</creator><creator>Andrés, M.I. San</creator><general>Elsevier India Pvt Ltd</general><general>Elsevier Limited</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20050601</creationdate><title>Pharmacokinetics of enrofloxacin following intravenous administration to greater rheas: a preliminary study</title><author>de Lucas, J.J. ; Rodríguez, C. ; Martella, M.B. ; Lábaque, M.C. ; Navarro, J.L. ; Andrés, M.I. San</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c406t-7ef14db6849dc15956d8500f9b953d843d19ffad291f7221261d0ab0eed835c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - administration &amp; dosage</topic><topic>Anti-Bacterial Agents - blood</topic><topic>Anti-Bacterial Agents - pharmacokinetics</topic><topic>Area Under Curve</topic><topic>Avian</topic><topic>Behavior</topic><topic>blood plasma</topic><topic>Ciprofloxacin</topic><topic>Ciprofloxacin - blood</topic><topic>Ciprofloxacin - pharmacokinetics</topic><topic>dosage</topic><topic>Drug therapy</topic><topic>Enrofloxacin</topic><topic>Fluoroquinolones</topic><topic>Fluoroquinolones - administration &amp; dosage</topic><topic>Fluoroquinolones - blood</topic><topic>Fluoroquinolones - pharmacokinetics</topic><topic>Half-Life</topic><topic>high performance liquid chromatography</topic><topic>Injections, Intravenous - veterinary</topic><topic>intravenous injection</topic><topic>Mortality</topic><topic>Pharmacokinetic</topic><topic>pharmacokinetics</topic><topic>Quinolones - administration &amp; dosage</topic><topic>Quinolones - blood</topic><topic>Quinolones - pharmacokinetics</topic><topic>Rhea</topic><topic>rheas</topic><topic>Rheiformes - metabolism</topic><topic>Software packages</topic><topic>ultraviolet-visible spectroscopy</topic><topic>Veterinary medicine</topic><topic>young animals</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Lucas, J.J.</creatorcontrib><creatorcontrib>Rodríguez, C.</creatorcontrib><creatorcontrib>Martella, M.B.</creatorcontrib><creatorcontrib>Lábaque, M.C.</creatorcontrib><creatorcontrib>Navarro, J.L.</creatorcontrib><creatorcontrib>Andrés, M.I. San</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Research in veterinary science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Lucas, J.J.</au><au>Rodríguez, C.</au><au>Martella, M.B.</au><au>Lábaque, M.C.</au><au>Navarro, J.L.</au><au>Andrés, M.I. San</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics of enrofloxacin following intravenous administration to greater rheas: a preliminary study</atitle><jtitle>Research in veterinary science</jtitle><addtitle>Res Vet Sci</addtitle><date>2005-06-01</date><risdate>2005</risdate><volume>78</volume><issue>3</issue><spage>265</spage><epage>267</epage><pages>265-267</pages><issn>0034-5288</issn><eissn>1532-2661</eissn><abstract>The pharmacokinetic behaviour of enrofloxacin (ENR) and its active metabolite ciprofloxacin (CIP) were determined in six greater rheas following a single intravenous (i.v.) dose of 15 mg/kg bw. Plasma concentrations of ENR and CIP were simultaneously determined by a HPLC/u.v. method. Following i.v. administration, the plasma drug concentrations were best fitted by an open two-compartment model with a rapid distribution phase. The high volume of distribution ( V ss = 5.01 L/Kg) suggests good tissue penetration. ENR presents a high clearance (3.95 L/kg h) explaining the low AUC values (3.57 mg h/L) and a short permanence (t 1/2β = 2.66 h and MRT = 1.23 h). Ciprofloxacin comprised 14% of the total fluoroquinolone (ENR + CIP).</abstract><cop>England</cop><pub>Elsevier India Pvt Ltd</pub><pmid>15766947</pmid><doi>10.1016/j.rvsc.2004.09.007</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0034-5288
ispartof Research in veterinary science, 2005-06, Vol.78 (3), p.265-267
issn 0034-5288
1532-2661
language eng
recordid cdi_proquest_miscellaneous_67514196
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Animals
Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - blood
Anti-Bacterial Agents - pharmacokinetics
Area Under Curve
Avian
Behavior
blood plasma
Ciprofloxacin
Ciprofloxacin - blood
Ciprofloxacin - pharmacokinetics
dosage
Drug therapy
Enrofloxacin
Fluoroquinolones
Fluoroquinolones - administration & dosage
Fluoroquinolones - blood
Fluoroquinolones - pharmacokinetics
Half-Life
high performance liquid chromatography
Injections, Intravenous - veterinary
intravenous injection
Mortality
Pharmacokinetic
pharmacokinetics
Quinolones - administration & dosage
Quinolones - blood
Quinolones - pharmacokinetics
Rhea
rheas
Rheiformes - metabolism
Software packages
ultraviolet-visible spectroscopy
Veterinary medicine
young animals
title Pharmacokinetics of enrofloxacin following intravenous administration to greater rheas: a preliminary study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T13%3A36%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics%20of%20enrofloxacin%20following%20intravenous%20administration%20to%20greater%20rheas:%20a%20preliminary%20study&rft.jtitle=Research%20in%20veterinary%20science&rft.au=de%20Lucas,%20J.J.&rft.date=2005-06-01&rft.volume=78&rft.issue=3&rft.spage=265&rft.epage=267&rft.pages=265-267&rft.issn=0034-5288&rft.eissn=1532-2661&rft_id=info:doi/10.1016/j.rvsc.2004.09.007&rft_dat=%3Cproquest_cross%3E2744856881%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1035032836&rft_id=info:pmid/15766947&rft_els_id=S0034528804001870&rfr_iscdi=true